Lanxess Said Close to Sale of Non-Core Rubber Units

German chemical producer Lanxess is said to be close to a sale of two of its rubber businesses which it last September identified as non-core and said it was studying "strategic options."

Activities initially named, including the Perlon-Monofil business line, rubber accelerators and antioxidants and nitrile-butadiene rubber, have combined sales of around €500 million and a workforce of around 1,000. They are based in Germany, Belgium, France, India and Nantong / China.

The two units said close to disposal have annual sales of €200 million, according to the news agency Reuters.

With the disposals and other restructuring activities, Lanxess is targeting savings of €100 million from 2015.

Reuters said the Cologne-based company, which is switching CEOs in the midst of a recently announced sharp deterioration of earnings and an expected loss for 2013, has hired the investment bank Macquarie to execute the divestment process.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.